1e
19
1
49
2
2
18
1b
1d
18
33
93
1d
2 29
1d
25
Wei-Ting Hwang, Ph.D.
78
93
Professor of Biostatistics in Biostatistics and Epidemiology at the Hospital of the University of Pennsylvania
28
b6
3
75
Member, Clinical Trials Scientific Review and Monitoring Committee (CTSRMC), University of Pennsylvania Abramson Cancer Center
98
Member, Biomedical Graduate Studies (BGS), University of Pennsylvania Perelman School of Medicine
b9
Senior Scholar, Center for Clinical Epidemiology and Biostatistics (CCEB), University of Pennsylvania Perelman School of Medicine
77
Member, Abramson Cancer Center (ACC), University of Pennsylvania
ab
Associate Fellow, Center for Health Behavior Research (CHBR), University of Pennsylvania Perelman School of Medicine
ac
Associate Fellow, Center for Public Health Initiatives (CPHI), University of Pennsylvania Perelman School of Medicine
c4
Faculty, Translational Research T32 Training Program in Environmental Health Sciences, University of Pennsylvania Perelman School of Medicine
c8
Associate Director, Center of Excellence in Environmental Toxicology (CEET) Integrative Health Sciences Facility Core (IHSFC) Biostatistics Group
99
Member, Research Core Facilities Committee, University of Pennsylvania Perelman School of Medicine
a2
Director, Biostatistics Core, Intraoperative Near Infrared Molecular Imaging of Lung Cancer Program Project
11
Department: Biostatistics and Epidemiology
4
1
23
1f
Graduate Group Affiliations
8
a
b
1d
46
Contact information
6e
4
3
3
1d
6e
Department of Biostatistics, Epidemiology and Informatics (DBEI)
41 Center for Clinical Epidemiology and Biostatistics (CCEB)
3f University of Pennsylvania Perelman School of Medicine
14 Room 3W 100A
3a 3600 Civic Center Blvd.
Philadelphia, PA 19104
26
41 Center for Clinical Epidemiology and Biostatistics (CCEB)
3f University of Pennsylvania Perelman School of Medicine
14 Room 3W 100A
3a 3600 Civic Center Blvd.
Philadelphia, PA 19104
33
Office: 215-573-5946
32 Fax: 215-573-4865
24
9b
12
32 Fax: 215-573-4865
24
18
Publications
23 a
3
2
29
23 a
Links
d9 Search PubMed for articles
45 Department faculty webpage
7f PSOM faculty webpage
7e Google scholar link
c
4
b
1f
d9 Search PubMed for articles
45 Department faculty webpage
7f PSOM faculty webpage
7e Google scholar link
c
13
Education:
21 9 B.S. 18 (Mathematics) c
3e National Tsing-Hua University, Taiwan, 1995.
21 a Ph.D. 1a (Biostatistics) c
56 Johns Hopkins University, School of Hygiene and Public Health, 2001.
c
3
3
3
3
8a
Permanent link21 9 B.S. 18 (Mathematics) c
3e National Tsing-Hua University, Taiwan, 1995.
21 a Ph.D. 1a (Biostatistics) c
56 Johns Hopkins University, School of Hygiene and Public Health, 2001.
c
2 29
21
1e
1d
24
5e
26 29
27
Description of Research Expertise
f0 Biostatistics, survival data analysis, longitudinal studies, clinical trials, translational cancer research, biomarker discovery and validation, environmental health sciences, instrument development for psychosocial research26 29
23
3d9 Jadlowsky JK, Hexner EO, Marshall A, Grupp SA, Frey NV, Riley JL, Veloso E, McConville H, Rogal W, Czuczman C, Hwang W-T, Li Y, Leskowitz RM, Farrelly O, Karar J, Christensen S, Barber-Rotenberg J, Gaymon A, Aronson N, Bernstein W, Melenhorst JJ, Roche AM, Everett JK, Zolnoski SA, McFarland AG, Reddy S, Petrichenko A, Cook EJ, Lee C, Gonzalez VE, Alexander K, Kulikovskaya I, Ramírez-Fernández Á, Minehart JC, Ruella M, Gill SI, Schuster SJ, Cohen AD, Garfall AL, Shah PD, Porter DL, Maude SL, Levine BL, Siegel DL, Chew A, McKenna S, Lledo L, Davis MM, Plesa G, Herbst F, Stadtmauer EA, Tebas P, DiNofia A, Haas A, Haas NB, Myers R, O'Rourke DM, Svoboda J, Tanyi JL, Aplenc R, Jacobson JM, Ko AH, Cohen RB, June CH, Bushman FD, Fraietta JA.: Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies. Nature Medicine 31(4): 1134-1144, Apr 2025 Notes: doi: 10.1038/s41591-024-03478-6.
129 Marks-Anglin AK, Barg FK, Ross M, Wiebe DJ, Hwang W-T: Survival analysis under imperfect record linkage using historic census data. BMC Medical Research Methodology 24(1): 67, Mar 2024 Notes: doi: 10.1186/s12874-024-02194-6.
15c Zhu AY, McWilliams TL, McKeon TP, Vachani A, Penning TM, Hwang W-T: Association of multi-criteria derived air toxics hazard score with lung cancer incidence in a major metropolitan area. Frontiers in Public Health 11: 1002597, Jun 2023 Notes: doi: 10.3389/fpubh.2023.1002597.
12e Camiña N, McWilliams TL, McKeon TP, Penning TM, Hwang W-T.: Identification of spatio-temporal clusters of lung cancer cases in Pennsylvania, USA: 2010-2017. BMC Cancer 22(1): 555, May 2022 Notes: doi: 10.1186/s12885-022-09652-8.
138 Ding Z, Ritchie MD, Voight BF, Hwang W-T: Estimating the effect size of a hidden causal factor between SNPs and a continuous trait: a mediation model approach. BMC Bioinformatics 23(1): 420, Oct 2022 Notes: doi: 10.1186/s12859-022-04977-4.
99 McKeon TP, Anil Vachani, Penning TM, Hwang W-T: Air pollution and lung cancer survival in Pennsylvania 64 Lung Cancer 170: 65-73, Aug 2022 Notes: doi: 10.1016/j.lungcan.2022.06.004.
97 Li Y, Hwang W-T, Maude SL, Teachey DT, Frey NV, Myers RM, Barz Leahy A, Liu H, Porter DL, Grupp SA, Shaw PA 99 : Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies 4f Clinical Cancer Research 28(18): 3940-3949, Sept 2022.
8b Ren B, Hwang W-T: Modeling post-holiday surge in COVID-19 cases in Pennsylvania counties 66 PLoS One 17(12): e0279371, Dec 2022 Notes: doi: 10.1371/journal.pone.0279371.
d1 Smith AM, Christodouleas JP, Hwang W-T*: Understanding the predictive value of continuous markers for censored survival data using a likelihood ratio approach 66 BMC Medical Research Methodology 19(1): 108, May 2019 Notes: * senior author.
126 Zhu Y, Hwang W-T, Li Y: Evaluating the effects of design parameters on the performances of phase I trial designs. Contemporary Clinical Trials Communications(15), 100379, May 2019 Notes: doi: 10.1016/j.conctc.2019.100379.
137 Yu D, Hwang W-T: Optimal cutoffs for continuous biomarkers for survival data under competing risks. Communications in Statistics - Simulation and Computation Page: 1-16, Jan 2018 Notes: *: Senior author. doi:10.1080/03610918.2017.1410713.
2c
7
1d
1f
Selected Publications
23a Puvvula J, Hwang W-T, McCandless L, Xie C, Braun JM, Vuong AM, Oulhote Y, Schisterman EF, Shinohara RT, Booij L, Bouchard MF, Linn K, Borghese MM, Seguin JR, Zidek A, Till C, Fraser W, Yolton K, Cecil KM, Ashley-Martin J, Arbuckle TE, Lanphear B, Chen A: Gestational exposure to environmental chemical mixtures and cognitive abilities in children: A pooled analysis of two North American birth cohorts. Environment International Page: 196:109298, Feb 2025 Notes: doi: 10.1016/j.envint.2025.109298.3d9 Jadlowsky JK, Hexner EO, Marshall A, Grupp SA, Frey NV, Riley JL, Veloso E, McConville H, Rogal W, Czuczman C, Hwang W-T, Li Y, Leskowitz RM, Farrelly O, Karar J, Christensen S, Barber-Rotenberg J, Gaymon A, Aronson N, Bernstein W, Melenhorst JJ, Roche AM, Everett JK, Zolnoski SA, McFarland AG, Reddy S, Petrichenko A, Cook EJ, Lee C, Gonzalez VE, Alexander K, Kulikovskaya I, Ramírez-Fernández Á, Minehart JC, Ruella M, Gill SI, Schuster SJ, Cohen AD, Garfall AL, Shah PD, Porter DL, Maude SL, Levine BL, Siegel DL, Chew A, McKenna S, Lledo L, Davis MM, Plesa G, Herbst F, Stadtmauer EA, Tebas P, DiNofia A, Haas A, Haas NB, Myers R, O'Rourke DM, Svoboda J, Tanyi JL, Aplenc R, Jacobson JM, Ko AH, Cohen RB, June CH, Bushman FD, Fraietta JA.: Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies. Nature Medicine 31(4): 1134-1144, Apr 2025 Notes: doi: 10.1038/s41591-024-03478-6.
129 Marks-Anglin AK, Barg FK, Ross M, Wiebe DJ, Hwang W-T: Survival analysis under imperfect record linkage using historic census data. BMC Medical Research Methodology 24(1): 67, Mar 2024 Notes: doi: 10.1186/s12874-024-02194-6.
15c Zhu AY, McWilliams TL, McKeon TP, Vachani A, Penning TM, Hwang W-T: Association of multi-criteria derived air toxics hazard score with lung cancer incidence in a major metropolitan area. Frontiers in Public Health 11: 1002597, Jun 2023 Notes: doi: 10.3389/fpubh.2023.1002597.
12e Camiña N, McWilliams TL, McKeon TP, Penning TM, Hwang W-T.: Identification of spatio-temporal clusters of lung cancer cases in Pennsylvania, USA: 2010-2017. BMC Cancer 22(1): 555, May 2022 Notes: doi: 10.1186/s12885-022-09652-8.
138 Ding Z, Ritchie MD, Voight BF, Hwang W-T: Estimating the effect size of a hidden causal factor between SNPs and a continuous trait: a mediation model approach. BMC Bioinformatics 23(1): 420, Oct 2022 Notes: doi: 10.1186/s12859-022-04977-4.
99 McKeon TP, Anil Vachani, Penning TM, Hwang W-T: Air pollution and lung cancer survival in Pennsylvania 64 Lung Cancer 170: 65-73, Aug 2022 Notes: doi: 10.1016/j.lungcan.2022.06.004.
97 Li Y, Hwang W-T, Maude SL, Teachey DT, Frey NV, Myers RM, Barz Leahy A, Liu H, Porter DL, Grupp SA, Shaw PA 99 : Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies 4f Clinical Cancer Research 28(18): 3940-3949, Sept 2022.
8b Ren B, Hwang W-T: Modeling post-holiday surge in COVID-19 cases in Pennsylvania counties 66 PLoS One 17(12): e0279371, Dec 2022 Notes: doi: 10.1371/journal.pone.0279371.
d1 Smith AM, Christodouleas JP, Hwang W-T*: Understanding the predictive value of continuous markers for censored survival data using a likelihood ratio approach 66 BMC Medical Research Methodology 19(1): 108, May 2019 Notes: * senior author.
126 Zhu Y, Hwang W-T, Li Y: Evaluating the effects of design parameters on the performances of phase I trial designs. Contemporary Clinical Trials Communications(15), 100379, May 2019 Notes: doi: 10.1016/j.conctc.2019.100379.
137 Yu D, Hwang W-T: Optimal cutoffs for continuous biomarkers for survival data under competing risks. Communications in Statistics - Simulation and Computation Page: 1-16, Jan 2018 Notes: *: Senior author. doi:10.1080/03610918.2017.1410713.
2c